Viking Therapeutics, Inc.
VKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001607678
In the last 90 days, Viking Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 437 institutions reported holding it in 13F filings for Q2 2026, worth $2.96B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Viking Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +23 vs. Q3 2022
- Shares held
- 34.1M
- +7.51M (+28.2%) vs. Q3 2022
- Total value
- $319.7M
- +$247.3M (+341.4%) vs. Q3 2022
- New holders
- 40
- 34 more added
- Sold out
- 17
- 34 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 437 | $2.96B |
| Q1 2026 | 414 | $2.43B |
| Q4 2025 | 427 | $2.54B |
| Q3 2025 | 371 | $1.87B |
| Q2 2025 | 392 | $2.02B |
| Q1 2025 | 373 | $1.88B |
| Q4 2024 | 409 | $3.30B |
| Q3 2024 | 422 | $5.27B |
| Q2 2024 | 388 | $4.26B |
| Q1 2024 | 373 | $6.56B |
| Q4 2023 | 197 | $1.42B |
| Q3 2023 | 179 | $854.0M |
| Q2 2023 | 193 | $1.21B |
| Q1 2023 | 185 | $1.11B |
| Q4 2022 | 129 | $319.7M |
| Q3 2022 | 107 | $72.4M |
| Q2 2022 | 115 | $77.2M |
| Q1 2022 | 140 | $93.8M |
| Q4 2021 | 140 | $166.5M |
| Q3 2021 | 135 | $237.7M |
| Q2 2021 | 138 | $226.9M |
| Q1 2021 | 144 | $259.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Viking Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 330,100 | $3.10M | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 347,517 | $3.27M | 0.03% | +57,245+19.7% | Added |
| Affinity Asset Advisors, LLC | 350,000 | $3.29M | 1.51% | +100,000+40.0% | Added |
| HRT Financial LP | 379,566 | $3.57M | 0.05% | +379,566 | New |
| Knott David M Jr | 381,621 | $3.59M | 1.55% | +79,818+26.4% | Added |
| Simplex Trading, LLC | 398,093 | $3.74M | 0.18% | +372,508+1,456.0% | Added |
| Endurant Capital Management LP | 433,035 | $4.07M | 1.65% | +433,035 | New |
| EAM Investors, LLC | 494,940 | $4.65M | 0.96% | +494,940 | New |
| DAFNA Capital Management LLC | 521,553 | $4.90M | 1.38% | −30,847−5.6% | Reduced |
| Morgan Stanley | 580,763 | $5.46M | 0.00% | +181,522+45.5% | Added |
| Integral Health Asset Management, LLC | 600,000 | $5.64M | 1.27% | +600,000 | New |
| Deep Track Capital, LP | 610,083 | $5.73M | 0.25% | +610,083 | New |
| Geode Capital Management, LLC | 654,306 | $6.15M | 0.00% | +1,269+0.2% | Added |
| Cormorant Asset Management, LP | 700,000 | $6.58M | 0.44% | +700,000 | New |
| Group One Trading, L.P. | 751,911 | $7.07M | 0.24% | +604,295+409.4% | Added |
| Susquehanna International Group, LLP | 820,858 | $7.72M | 0.02% | +346,619+73.1% | Added |
| Dimensional Fund Advisors LP | 848,727 | $7.98M | 0.00% | −65,236−7.1% | Reduced |
| Octagon Capital Advisors LP | 870,500 | $8.18M | 1.27% | +870,500 | New |
| Two Sigma Advisers, LP | 947,028 | $8.90M | 0.02% | +40,400+4.5% | Added |
| Renaissance Technologies LLC | 950,600 | $8.94M | 0.01% | −95,800−9.2% | Reduced |
| D. E. Shaw & Co., Inc. | 951,240 | $8.94M | 0.02% | +937,374+6,760.2% | Added |
| Point72 Asset Management, L.P. | 1,105,600 | $10.4M | 0.04% | +1,105,600 | New |
| Two Sigma Investments, LP | 1,265,188 | $11.9M | 0.04% | +278,865+28.3% | Added |
| Great Point Partners LLC | 1,295,034 | $12.2M | 2.52% | +1,295,034 | New |
| Laurion Capital Management LP | 1,299,000 | $12.2M | 0.34% | 00.0% | Unchanged |
| BlackRock Inc. | 1,346,013 | $12.7M | 0.00% | −120,243−8.2% | Reduced |
| Boxer Capital, LLC | 1,500,000 | $14.1M | 0.76% | +1,500,000 | New |
| Vanguard Group Inc | 3,325,671 | $31.3M | 0.00% | −5,418−0.2% | Reduced |
| Millennium Management LLC | 4,382,500 | $41.2M | 0.05% | +1,279,469+41.2% | Added |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −487,313−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −247,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −198,164−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −46,758−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −46,186−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −30,753−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −29,258−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,941−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −14,810−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,382−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −10,840−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| PYA Waltman Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |